FDA approves Ionis drug Tryngolza for severe hypertriglyceridemia
Go back to FDA approves Ionis drug Tryngolza for severe hypertriglyceridemia| (NASDAQ: IONS) | Delayed: 56.03 -0.68 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.71 | 52 Week High | $62.68 | |||
| Open | $56.38 | 52 Week Low | $19.59 | |||
| Day High | $56.96 | P/E | N/A | |||
| Day Low | $55.70 | EPS | $0.00 | |||
| Volume | 2,274,272 | |||||

